KANSAS CITY ORTHOPAEDIC INSTITUTE — History
CCN 170188 | 3-year financial timeline | COVID resilience: 54/100
🛡️ Public data only — no PHI permitted on this instance.
$86M
Latest Revenue (FY2022)
+15.5%
Revenue CAGR (3yr)
21.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $65M | $82M | $86M | +5.9% | +15.5% |
| Operating Expenses | $46M | $58M | $68M | +17.1% | +21.3% |
| Operating Margin | 28.4% | 28.7% | 21.1% | -26.5% | -13.9% |
| Net Income | $18M | $23M | $18M | -22.2% | -0.5% |
| Licensed Beds | 17 | 17 | 17 | +0.0% | +0.0% |
| Total Patient Days | 4,231 | 1,792 | 1,979 | +10.4% | -31.6% |
| Medicare Day % | 24% | 62% | 64% | +2.3% | +63.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 54/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +33.4% ($65M → $86M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+15.5%
This Hospital
+7.6%
State Avg
Latest Margin
21.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $97M | 17.4% |
| FY2024 (proj) | $108M | 13.8% |
| FY2025 (proj) | $119M | 10.1% |